Vascular Precursor Cells

Genes and Cancer

Volumn 2, Issue 12, 2011, Pages 1081-1084

  Chaudhury, Hera ^a,b   Goldie, Lauren C ^a,b   Hirschi, Karen K ^a,b,c  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

embryonic stem cells; endothelial cell differentiation; induced pluripotent stem cells; vascular precursors

Indexed keywords

ADULT STEM CELL; ARTICLE; CELL DIFFERENTIATION; CELL POPULATION; CELL TYPE; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; HUMAN; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 84868611490     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911432335     Document Type: Article

References (63)

1. Blau HM,Brazelton TR,Weimann JM.The evolving concept of a stem cell: entity or function?.Cell. 2001;105:829-41.
2. Amabile G,Meissner A.Induced pluripotent stem cells: current progress and potential for regenerative medicine.Trends Mol Med. 2009;15:59-68.
3. Putnam AJ,Mooney DJ.Tissue engineering using synthetic extracellular matrices.Nat Med. 1996;2:824-6.
4. Shin H,Jo S,Mikos AG.Biomimetic materials for tissue engineering.Biomaterials. 2003;24:4353-64.
5. Lutolf MP,Hubbell JA.Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering.Nat Biotech. 2005;23:47-55.
6. Badylak SF.The extracellular matrix as a biologic scaffold material.Biomaterials. 2007;28:3587-93.
7. Niklason LE,Gao J,Abbott WM, et al.Functional arteries grown in vitro.Science. 1999;284:489-93.
8. Atala A,Bauer SB,Soker S,Yoo JJ,Retik AB.Tissue-engineered autologous bladders for patients needing cystoplasty.Lancet. 2006;367:1241-6.
9. Asahara T,Murohara T,Sullivan A, et al.Isolation of putative progenitor endothelial cells for angiogenesis.Science. 1997;275:964-6.
10. Castro-Malaspina H,Gay RE,Resnick G.Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny.Blood. 1980;56:289-301.
11. Galmiche MC,Koteliansky VE,Briere J,Herve P,Charbord P.Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway.Blood. 1993;82:66-76.
12. Nieda M,Nicol A,Denning-Kendall P,Sweetenham J,Bradley B,Hows J.Endothelial cell precursors are normal components of human umbilical cord blood.Br J Haematol. 1997;98:775-7.
13. Kalka C,Masuda H,Takahashi T, et al.Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A. 2000;97:3422-7.
14. Murohara T,Ikeda H,Duan J, et al.Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization.J Clin Invest. 2000;105:1527-36.
15. Zuk PA,Zhu M,Mizuno H, et al.Multilineage cells from human adipose tissue: implications for cell-based therapies.Tissue Eng. 2001;7:211-28.
16. Crisan M,Yap S,Casteilla L, et al.A perivascular origin for mesenchymal stem cells in multiple human organs.Cell Stem Cell. 2008;3:301-13.
17. Peichev M,Naiyer AJ,Pereira D, et al.Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors.Blood. 2000;95:952-8.
18. Chao H,Hirschi KK.Hemato-vascular origins of endothelial progenitor cells?.Microvasc Res. 2010;79:169-73.
19. Hirschi KK,Ingram DA,Yoder MC.Assessing identity, phenotype, and fate of endothelial progenitor cells.Arterioscler Thromb Vasc Biol. 2008;28:1584-95.
20. Evans MJ,Kaufman MH.Establishment in culture of pluripotential cells from mouse embryos.Nature. 1981;292:154-6.
21. Martin GR.Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.Proc Natl Acad Sci U S A. 1981;78:7634-8.
22. Thomson JA,Itskovitz-Eldor J,Shapiro SS, et al.Embryonic stem cell lines derived from human blastocysts.Science. 1998;282:1145-7.
23. Takahashi K,Tanabe K,Ohnuki M, et al.Induction of pluripotent stem cells from adult human fibroblasts by defined factors.Cell. 2007;131:861-72.
24. Yu J,Vodyanik MA,Smuga-Otto K, et al.Induced pluripotent stem cell lines derived from human somatic cells.science. 2007;318:1917-20.
25. Levenberg S,Golub JS,Amit M,Itskovitz-Eldor J,Langer R.Endothelial cells derived from human embryonic stem cells.Proc Natl Acad Sci U S A. 2002;99:4391-6.
26. Itskovitz-Eldor J,Schuldiner M,Karsenti D, et al.Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers.Mol Med. 2000;6:88-95.
27. Levenberg S,Ferreira LS,Chen-Konak L,Kraehenbuehl TP,Langer R.Isolation, differentiation and characterization of vascular cells derived from human embryonic stem cells.Nat Protoc. 2010;5:1115-26.
28. Nakano T,Kodama H,Honjo T.Generation of lymphohematopoietic cells from embryonic stem cells in culture.Science. 1994;265:1098-101.
29. Vodyanik MA,Bork JA,Thomson JA,Slukvin II.Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential.Blood. 2005;105:617-26.
30. Kelly MA,Hirschi KK.Signaling hierarchy regulating human endothelial cell development.Arterioscler Thromb Vasc Biol. 2009;29:718-24.
31. Xu C,Inokuma MS,Denham J, et al.Feeder-free growth of undifferentiated human embryonic stem cells.Nat Biotech. 2001;19:971-4.
32. Kane NM,Meloni M,Spencer HL, et al.Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of MicroRNA and angiogenesis in vitro and in vivo.Arterioscler Thromb Vasc Biol. 2010;30:1389-97.
33. Yamashita J,Itoh H,Hirashima M, et al.Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors.Nature. 2000;408:92-6.
34. Farrington SM,Belaoussoff M,Baron MH.Winged-Helix, Hedgehog and Bmp genes are differentially expressed in distinct cell layers of the murine yolk sac.Mech Dev. 1997;62:197-211.
35. Dyer MA,Farrington SM,Mohn D,Munday JR,Baron MH.Indian hedgehog activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo.Development. 2001;128:1717-30.
36. Carmeliet P,Ferreira V,Breier G, et al.Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.Nature. 1996;380:435-9.
37. Ferrara N,Carver-Moore K,Chen H, et al.Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.Nature. 1996;380:439-42.
38. Leconte I,Fox JC,Baldwin HS,Buck CA,Swain JL.Adenoviral-mediated expression of antisense RNA to fibroblast growth factors disrupts murine vascular development.Dev Dyn. 1998;213:421-30.
39. Lee SH,Schloss DJ,Swain JL.Maintenance of vascular integrity in the embryo requires signaling through the fibroblast growth factor receptor.J Biol Chem. 2000;275:33679-87.
40. Iacobas I,Vats A,Hirschi KK.Vascular potential of human pluripotent stem cells.Arterioscler Thromb Vasc Biol. 2010;30:1110-7.
41. Wang H,Charles PC,Wu Y, et al.Gene expression profile signatures indicate a role for wnt signaling in endothelial commitment from embryonic stem cells.Circ Res. 2006;98:1331-9.
42. Wang L,Li L,Shojaei F, et al.Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties.Immunity. 2004;21:31-41.
43. Bai H,Gao Y,Arzigian M,Wojchowski DM,Wu WS,Wang ZZ.BMP4 regulates vascular progenitor development in human embryonic stem cells through a smad-dependent pathway.J Cell Biochem. 2010;109:363-74.
44. Smadja DM,Bieche I,Silvestre JS, et al.Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis.Arterioscler Thromb Vasc Biol. 2008;28:2137-43.
45. Belmokhtar K,Bourguignon T,Worou M, et al.Regeneration of three layers vascular wall by using BMP2-treated MSC involving HIF-1a and Id1 expressions through JAK/STAT pathways.Stem Cell Rev. 2011;:1-13.
46. Forsythe JA,Jiang BH,Iyer NV, et al.Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.Mol Cell Biol. 1996;16:4604-13.
47. Semenza GL.HIF-1: mediator of physiological and pathophysiological responses to hypoxia.J Appl Physiol. 2000;88:1474-80.
48. Min JK,Park H,Choi HJ, et al.The WNT antagonist Dickkopf2 promotes angiogenesis in rodent and human endothelial cells.J Clin Invest. 2011;121:1882-93.
49. Rossig L,Urbich C,Bruhl T, et al.Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells.J Exp Med. 2005;201:1825-35.
50. Takahashi K,Yamanaka S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.Cell. 2006;126:663-76.
51. Woltjen K,Michael IP,Mohseni P, et al.piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells.Nature. 2009;458:766-70.
52. Carey BW,Markoulaki S,Hanna J, et al.Reprogramming of murine and human somatic cells using a single polycistronic vector.Proc Natl Acad Sci U S A. 2009;106:157-62.
53. Narsinh KH,Jia F,Robbins RC,Kay MA,Longaker MT,Wu JC.Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors.Nat Protoc. 2010;6:78-88.
54. Lee CH,Kim JH,Lee HJ, et al.The generation of iPS cells using non-viral magnetic nanoparticlebased transfection.Biomaterials. 2011;32:6683-91.
55. Montserrat N,Garreta E,Gonzalez F, et al.Simple generation of human induced pluripotent stem cells using poly-beta-amino esters as the non-viral gene delivery system.J Biol Chem. 2011;286:12417-28.
56. Mali P,Ye Z,Hommond HH, et al.Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts.Stem Cells. 2008;26:1998-2005.
57. Schenke-Layland K,Rhodes KE,Angelis E, et al.Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages.Stem Cells. 2008;26:1537-46.
58. Mauritz C,Martens A,Rojas SV, et al.Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction.Eur Heart J. 2011;32:2634-41.
59. Xie C,Hu J,Ma H, et al.Three-dimensional growth of iPS cell-derived smooth muscle cells on nanofibrous scaffolds.Biomaterials. 2011;32:4369-75.
60. Christodoulou C,Longmire TA,Shen SS, et al.Mouse ES and iPS cells can form similar definitive endoderm despite differences in imprinted genes.J Clin Invest. 2011;121:2313-25.
61. Narsinh KH,Sun N,Sanchez-Freire V, et al.Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells.J Clin Invest. 2011;121:1217-21.
62. Wang Y,Umeda K,Nakayama N.Collaboration between WNT and BMP signaling promotes hemoangiogenic cell development from human fibroblast-derived iPS cells.Stem Cell Res. 2010;4:223-31.
63. Feng Q,Lu SJ,Klimanskaya I, et al.Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence.Stem Cells. 2010;28:704-12.